The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the ...

An online calculator for the modified Rodnan skin score (mRss) in systemic sclerosis | by RheumCalc

To assess the course of modified Rodnan skin score (MRSS) in patients with diffuse cutaneous systemic sclerosis (dcSSc) with different baseline disease durations (defined from the date of onset of first non-Raynaud’s phenomenon symptom) in 3 large randomized controlled trials (RCT).

Modified Rankin Scale for Neurologic Disability Measures the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.

This score consists of an evaluation of patient’s skin thickness rated by clinical palpation using a 0–3 scale (0=normal skin; 1=mild thickness; 2=moderate thickness; 3=severe thickness with inability to pinch the skin into a fold) for each of 17 surface anatomic areas of the body: face, anterior chest, abdomen, (right and left separately) finge...

2021年7月29日 · The modified Rankin Scale (mRS), a 7-level, clinician-reported, measure of global disability, is the most widely employed outcome scale in acute stroke trials. The scale’s original development preceded the advent of modern clinimetrics, but substantial subsequent work has been performed to enable the mRS to meet robust contemporary scale ...

2017年1月1日 · This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.

2017年2月2日 · This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.

用于评价各类脑卒中患者预后状况，康复期患者功能残疾水平的疗效判定。 优势. 1、操作简便，通过简单询问可得出评分； 2、 mRS 作为功能残疾水平的疗效判定指标，具有较好的可靠性和真实性，标准的 mRS 评估方法是评估者与患者之间进行直接面谈。 3、 mRS 量表中没有体格检查的相关内容，因此可以实现通过电话或者问卷等形式实现远程评估。 与其他量表的比较. 与改良Barthel评分相比，无细节的日常生活具体指标，评估方法相对主观，且需要评定员对等级划分 …

The Modified Rankin Scale (MRS) is a single item, global outcomes rating scale for patients post-stroke. It is used to categorize level of functional independence with reference to pre-stroke activities rather than on observed performance of a specific task.